In the hippocampus, expression of GR and Creb3, a modulator of GR sensitivity, were consistently reduced in C5aR1 knockout mice, suggesting an overall genotype-specific alteration in sensitivity to glucocorticoids, a phenotype also observed in patients with diabetes (40). This evidence concerns the gene CREB3 and diabetes mellitus.